139 related articles for article (PubMed ID: 26163234)
1. Vertical Trabeculae are Thinned More Than Horizontal Trabeculae in Skeletal-Unloaded Rats.
Vegger JB; Brüel A; Thomsen JS
Calcif Tissue Int; 2015 Nov; 97(5):516-26. PubMed ID: 26163234
[TBL] [Abstract][Full Text] [Related]
2. Age-related changes of vertical and horizontal lumbar vertebral trabecular 3D bone microstructure is different in women and men.
Thomsen JS; Niklassen AS; Ebbesen EN; Brüel A
Bone; 2013 Nov; 57(1):47-55. PubMed ID: 23899636
[TBL] [Abstract][Full Text] [Related]
3. Additive effect of PTH (1-34) and zoledronate in the prevention of disuse osteopenia in rats.
Vegger JB; Nielsen ES; Brüel A; Thomsen JS
Bone; 2014 Sep; 66():287-95. PubMed ID: 24970039
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone mitigates loss of periosteal bone formation and muscle mass in disuse osteopenic rats.
Grubbe MC; Thomsen JS; Nyengaard JR; Duruox M; Brüel A
J Musculoskelet Neuronal Interact; 2014 Dec; 14(4):473-83. PubMed ID: 25524973
[TBL] [Abstract][Full Text] [Related]
5. PTH (1-34) and growth hormone in prevention of disuse osteopenia and sarcopenia in rats.
Brent MB; Brüel A; Thomsen JS
Bone; 2018 May; 110():244-253. PubMed ID: 29475111
[TBL] [Abstract][Full Text] [Related]
6. Effects of risedronate in a rat model of osteopenia due to orchidectomy and disuse: densitometric, histomorphometric and microtomographic studies.
Libouban H; Blouin S; Moreau MF; Baslé MF; Audran M; Chappard D
Micron; 2008 Oct; 39(7):998-1007. PubMed ID: 18023586
[TBL] [Abstract][Full Text] [Related]
7. Disuse-induced loss of bone mineral density and bone strength is attenuated by post-lactational bone gain in NMRI mice.
Sørensen TG; Brent MB; Thomsen JS; Brüel A
Bone; 2020 Feb; 131():115183. PubMed ID: 31794846
[TBL] [Abstract][Full Text] [Related]
8. Loss of bone strength is dependent on skeletal site in disuse osteoporosis in rats.
Thomsen JS; Christensen LL; Vegger JB; Nyengaard JR; Brüel A
Calcif Tissue Int; 2012 Apr; 90(4):294-306. PubMed ID: 22354132
[TBL] [Abstract][Full Text] [Related]
9. Comparison between quantitative X-ray imaging, dual energy X-ray absorptiometry and microCT in the assessment of bone mineral density in disuse-induced bone loss.
Mabilleau G; Mieczkowska A; Libouban H; Simon Y; Audran M; Chappard D
J Musculoskelet Neuronal Interact; 2015 Mar; 15(1):42-52. PubMed ID: 25730651
[TBL] [Abstract][Full Text] [Related]
10. Long-Term High-Dose Resveratrol Supplementation Reduces Bone Mass and Fracture Strength in Rats.
Ornstrup MJ; Brüel A; Thomsen JS; Harsløf T; Langdahl BL; Pedersen SB
Calcif Tissue Int; 2018 Mar; 102(3):337-347. PubMed ID: 29058054
[TBL] [Abstract][Full Text] [Related]
11. Disuse and orchidectomy have additional effects on bone loss in the aged male rat.
Blouin S; Gallois Y; Moreau MF; Baslé MF; Chappard D
Osteoporos Int; 2007 Jan; 18(1):85-92. PubMed ID: 17019521
[TBL] [Abstract][Full Text] [Related]
12. Of mice, rats and men: trabecular bone architecture in mammals scales to body mass with negative allometry.
Barak MM; Lieberman DE; Hublin JJ
J Struct Biol; 2013 Aug; 183(2):123-31. PubMed ID: 23639903
[TBL] [Abstract][Full Text] [Related]
13. Rodent model of disuse-induced bone loss by hind limb injection with botulinum toxin A.
Brent MB; Lodberg A; Thomsen JS; Brüel A
MethodsX; 2020; 7():101079. PubMed ID: 33083241
[TBL] [Abstract][Full Text] [Related]
14. Muscle and bone follow similar temporal patterns of recovery from muscle-induced disuse due to botulinum toxin injection.
Manske SL; Boyd SK; Zernicke RF
Bone; 2010 Jan; 46(1):24-31. PubMed ID: 19853070
[TBL] [Abstract][Full Text] [Related]
15. Anti-sclerostin antibodies and abaloparatide have additive effects when used as a countermeasure against disuse osteopenia in female rats.
Brent MB; Brüel A; Thomsen JS
Bone; 2022 Jul; 160():116417. PubMed ID: 35398589
[TBL] [Abstract][Full Text] [Related]
16. Disuse osteopenia induced by botulinum toxin is similar in skeletally mature young and aged female C57BL/6J mice.
Vegger JB; Brüel A; Brent MB; Thomsen JS
J Bone Miner Metab; 2018 Mar; 36(2):170-179. PubMed ID: 28365811
[TBL] [Abstract][Full Text] [Related]
17. The Efficacy of PTH and Abaloparatide to Counteract Immobilization-Induced Osteopenia Is in General Similar.
Brent MB; Thomsen JS; Brüel A
Front Endocrinol (Lausanne); 2020; 11():588773. PubMed ID: 33162940
[TBL] [Abstract][Full Text] [Related]
18. Differences of three-dimensional trabecular microstructure in osteopenic rat models caused by ovariectomy and neurectomy.
Ito M; Nishida A; Nakamura T; Uetani M; Hayashi K
Bone; 2002 Apr; 30(4):594-8. PubMed ID: 11934651
[TBL] [Abstract][Full Text] [Related]
19. PTH (1-34), but not strontium ranelate counteract loss of trabecular thickness and bone strength in disuse osteopenic rats.
Brüel A; Vegger JB; Raffalt AC; Andersen JE; Thomsen JS
Bone; 2013 Mar; 53(1):51-8. PubMed ID: 23246791
[TBL] [Abstract][Full Text] [Related]
20. Texture analysis of X-ray radiographs is a more reliable descriptor of bone loss than mineral content in a rat model of localized disuse induced by the Clostridium botulinum toxin.
Chappard D; Chennebault A; Moreau M; Legrand E; Audran M; Basle MF
Bone; 2001 Jan; 28(1):72-9. PubMed ID: 11165945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
